ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01650051
Recruitment Status : Completed
First Posted : July 26, 2012
Last Update Posted : June 26, 2014
Sponsor:
Collaborator:
Symbio, LLC
Information provided by (Responsible Party):
Amneal Pharmaceuticals, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2013
  Actual Study Completion Date : February 2014
  Certification/Extension First Submitted : June 25, 2014